Rhythm Pharmaceuticals (RYTM) Stock Highlights

59.36 | -1.02%

2024-11-21 01:58:07

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The companys product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Statistics

Range Today

58.08 60.71

Volume Today 370.51K

Range 1 Year

31.52 68.58

Volume 1 Year 145.38M

Range 3 Year

3.04 68.58

Volume 3 Year 596.37M

Range 10 Year

3.04 68.58

Volume 10 Year 850.52M

Highlights

Market Capitalization 4.14B (mid)

Floating Shares 45.16M

Current Price 59.36

Price To Earnings -13.86

Price To Revenue 36.38

Price To Book 367.92

Earnings Per Share -4.55

Payout Ratio 0%

Performance

Latest -1.02%

1 Month +14.15%

3 Months +26.27%

6 Months +56.29%

1 Year +74.74%

3 Years +475.19%

5 Years +169.21%

10 Years +133.24%

Benchmarks

Market Capitalization

64 / 368

Gross Profits

85 / 278

Total Revenue

110 / 300

Total Rank

251 / 368

Free Cashflow

278 / 352

Performance 5 years

50 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.